S100A11 and liver cancer: To further confirm that PCK1 exerted antitumor effects through S100A11 suppression via upregulation of H3K9me3 modification in vivo, we developed a DEN/CCl4/PB-induced mouse model of liver cancer (Figure 7A and Supplemental Figure 6A) (37).